The Failure in NGF Maturation and its Increased Degradation as the Probable Cause for the Vulnerability of Cholinergic Neurons in Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurochemical Research

• Publication date

  2007-04-03

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/s11064-006-9270-0PMID 17404842
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade.

  2006influential reference
• Altered synaptic function in Alzheimer's disease.

  2006cited by this paper
• Sortilin is essential for proNGF-induced neuronal cell death

  2004cited by this paper
• Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury.

  2004cited by this paper
• The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.

  2001cited by this paper
• Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.

  2000cited by this paper
• Treatment with the Selective Muscarinic Agonist Talsaclidine Decreases Cerebrospinal Fluid Levels of Total Amyloid β‐Peptide in Patients with Alzheimer's Disease

  2000cited by this paper
• A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat.

  1999cited by this paper
• Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex.

  1996cited by this paper
• Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis

  1995cited by this paper
• NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients.

  1994cited by this paper
• Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.

  1992cited by this paper
• Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease.

  1986cited by this paper
• The anatomy of the CNS cholinergic neurons

  1984cited by this paper
• Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage.

  1983cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

  1976cited by this paper

• The dependence of basal forebrain cholinergic neurons on NGF: The case in Alzheimer pathology.

  2025cites this paper
• Neuroprotective Effects of Rosa damascena Essential Oil Against Ethanol-Induced Toxicity in Neural Progenitor Cells

  2025cites this paper
• Therapeutic modulation of neurogenesis to improve hippocampal plasticity and cognition in aging and Alzheimer's disease

  2025cites this paper
• The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors

  2024cites this paper
• Cortical Brain Injury Causes Retrograde Degeneration of Afferent Basal Forebrain Cholinergic Neurons via the p75NTR

  2023cites this paper
• Analysis of β-nerve growth factor and its precursor during human pregnancy by immunoaffinity-liquid chromatography tandem mass spectrometry

  2023cites this paper
• Astrocytes and Brain-Derived Neurotrophic Factor (BDNF).

  2023cites this paper
• Neuroprotective Effect of Wharton's Jelly-Derived Mesenchymal Stem Cell-Conditioned Medium (WJMSC-CM) on Diabetes-Associated Cognitive Impairment by Improving Oxidative Stress, Neuroinflammation, and Apoptosis

  2023influential citation
• Combination Therapy with Platelet-Rich Plasma and Epidermal Neural Crest Stem Cells Increases Treatment Efficacy in Vascular Dementia

  2023cites this paper
• Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease

  2022cites this paper
• The Molecular Effects of Environmental Enrichment on Alzheimer’s Disease

  2022cites this paper
• The neuroprotective properties and therapeutic potential of epidermal neural crest stem cells transplantation in a rat model of vascular dementia.

  2021cites this paper
• Elevated Levels of miR-144-3p Induce Cholinergic Degeneration by Impairing the Maturation of NGF in Alzheimer’s Disease

  2021cites this paper
• Anti-neurodegenerative benefits of acetylcholinesterase inhibitors in Alzheimer's disease: Nexus of cholinergic and nerve growth factor dysfunction.

  2021cites this paper
• Construction and preliminary characterization of human recombinant proNGF-A variant.

  2020cites this paper
• Young Blood Rescues the Cognition of Alzheimer's Model Mice by Restoring the Hippocampal Cholinergic Circuit.

  2019cites this paper
• Different responses of PC12 cells to different pro-nerve growth factor protein variants.

  2019cites this paper
• Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF

  2019cites this paper
• ProNGF and Neurodegeneration in Alzheimer’s Disease

  2019cites this paper
• The emerging roles of protein homeostasis‐governing pathways in Alzheimer's disease

  2018cites this paper
• Factors that influence adult neurogenesis as potential therapy

  2018cites this paper
• Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm.

  2017cites this paper
• Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease.

  2017cites this paper
• The multifaceted role of metalloproteinases in physiological and pathological conditions in embryonic and adult brains.

  2017cites this paper
• Cholinergic modulation of the mesostriatal pathway

  2016cites this paper
• The neglected role of copper ions in wound healing.

  2016cites this paper
• The mature/pro nerve growth factor ratio is decreased in the brain of diabetic rats: Analysis by ELISA methods.

  2015cites this paper
• The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease.

  2015cites this paper
• Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders

  2015cites this paper
• Imbalance of the Nerve Growth Factor and Its Precursor as a Potential Biomarker for Diabetic Retinopathy

  2015cites this paper
• Role of Neurotrophic Factor Alterations in the Neurodegenerative Process in HIV Associated Neurocognitive Disorders

  2014cites this paper
• Can proline-rich polypeptide complex mimic the effect of nerve growth factor?

  2014cites this paper
• Substitution of natural sensory input by artificial neurostimulation of an amputated trigeminal nerve does not prevent the degeneration of basal forebrain cholinergic circuits projecting to the somatosensory cortex

  2014cites this paper
• Pharmacological treatment for Alzheimer’s disease

  2014cites this paper
• Astrogliosis as a therapeutic target for neurodegenerative diseases.

  2014cites this paper
• Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer’s Disease

  2013cites this paper
• LPS-Induced proNGF Synthesis and Release in the N9 and BV2 Microglial Cells: A New Pathway Underling Microglial Toxicity in Neuroinflammation

  2013cites this paper
• APP Regulates NGF Receptor Trafficking and NGF-Mediated Neuronal Differentiation and Survival

  2013cites this paper
• Presence of proNGF-Sortilin Signaling Complex in Nigral Dopamine Neurons and Its Variation in Relation to Aging, Lactacystin and 6-OHDA Insults

  2013cites this paper
• NGF and APP Interplay: Focus on YENPTY Motif of Amyloid Precursor Protein and Y682 Residue

  2013cites this paper
• proNGF Inhibits Neurogenesis and Induces Glial Activation in Adult Mouse Dentate Gyrus

  2013cites this paper
• Paeoniflorin attenuates amyloid-beta peptide-induced neurotoxicity by ameliorating oxidative stress and regulating the NGF-mediated signaling in rats.

  2013cites this paper
• Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease

  2013cites this paper
• An expanding range of targets for kynurenine metabolites of tryptophan.

  2013cites this paper
• AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease

  2012cites this paper
• Association between Nerve Growth Factor Gene Polymorphism and Executive Dysfunction in Japanese Patients with Early-Stage Alzheimer’s Disease and Amnestic Mild Cognitive Impairment

  2012cites this paper
• Targeting reactive astrogliosis by novel biotechnological strategies.

  2012cites this paper
• Alzheimer's disease and amyloid: culprit or coincidence?

  2012cites this paper
• Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment

  2012cites this paper
• Impact of the NGF Maturation and Degradation Pathway on the Cortical Cholinergic System Phenotype

  2012cites this paper
• Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor.

  2011cites this paper
• Neuroregeneration in neurodegenerative disorders

  2011cites this paper
• Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.

  2011cites this paper
• Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease

  2010cites this paper
• Transgenic Mice with Chronic NGF Deprivation and Alzheimer's Disease-Like Pathology Display Hippocampal Region-Specific Impairments in Short- and Long-Term Plasticities

  2010cites this paper
• Alzheimer's disease: from pathology to therapeutic approaches.

  2009cites this paper
• Neuroprotective and Neurotrophic Effects of Isorosmanol

  2009cites this paper
• Enhanced neuronal loss under perinatal hypothyroidism involves impaired neurotrophic signaling and increased proteolysis of p75(NTR).

  2009cites this paper
• Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen

  2009cites this paper
• Subtilisin-like proprotein convertase expression, localization, and activity in the human retina and optic nerve head.

  2009cites this paper
• p75NTR Expression is induced in isolated neurons of the penumbra after ischemia by cortical devascularization

  2009cites this paper
• Mood, memory and movement: an age-related neurodegenerative complex?

  2008cites this paper
• Inflammation causes expression of NGF in epithelial cells of the rat colon.

  2008cites this paper
• Tandem repeat peptide strategy for the design of neurotrophic factor mimetics.

  2008cites this paper
• Small molecule modulation of p75 neurotrophin receptor functions.

  2008cites this paper
• SNPs in Neurotrophin System Genes and Alzheimer's Disease in an Italian Population

  2008cites this paper